Please provide your email address to receive an email when new articles are posted on . Steven Yeh, MD, of Truhlsen Eye Institute, University of Nebraska Medical Center, said by 4 weeks, patients with ...
Please provide your email address to receive an email when new articles are posted on . NEW YORK — In this Healio Video Perspective from the ASRS meeting, Christopher R. Henry, MD, discusses results ...
Karacorlu et al's article on the use of intravitreal triamcinolone in patients with diabetic macular oedema and no previous laser treatment suggested that there was some beneficial effect in the short ...
Percutaneous injection of triamcinolone improves margin reflex distance 1 (MRD1) and upper eyelid retraction (UER) in thyroid eye disease. "Percutaneous triamcinolone injection is an effective and ...
XIPERE™ is the First and Only Medicine to be Approved in the United States for Delivery via Suprachoroidal Injection, a Method Designed to Facilitate Targeted Delivery of Therapeutic Agents to the ...
ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results